Insider · CIK 0001816720

Akamine Scott

Reports to the SEC for 2 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001816720

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-16	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+60K sh	—	—	60,000
2026-04-16	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+60K sh	—	—	60,000
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−7,527 sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−367K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Legal Officer	DDisposition to Issuer	−59.2K sh	—	—	0
2024-01-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Chief Legal Officer	AAward	+59.2K sh	—	—	59,171
2023-12-20	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Legal Officer	SSale	−7,072 sh	$41.42	−$293K	7,237
2023-12-19	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+13.8K sh	—	—	14,309
2023-12-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−13.8K sh	—	—	0
2023-12-07	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+10K sh	$13.17	+$132K	10,513
2023-12-07	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Legal Officer	SSale	−10K sh	$41.37	−$414K	513
2023-12-07	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−10K sh	—	—	254,262
2023-12-05	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+7,500 sh	$13.17	+$98.8K	8,013
2023-12-05	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Legal Officer	SSale	−7,500 sh	$35.00	−$263K	513
2023-12-05	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−7,500 sh	—	—	264,262
2023-02-06	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+54.3K sh	—	—	54,292
2023-02-06	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Chief Legal Officer	AAward	+13.8K sh	—	—	13,796
2022-08-08	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+10K sh	$13.17	+$132K	10,000
2022-08-08	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Legal Officer	SSale	−10K sh	$40.00	−$400K	0
2022-08-08	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−10K sh	—	—	271,762
2022-02-09	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+58.6K sh	—	—	58,572
2021-06-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+282K sh	—	—	281,762

Recent filings

Accepted (ET)
Apr 204
Akamine Scott0001193125-26-164306
SEC(opens sec.gov)
Aug 54
Akamine Scott0000950170-24-090841
SEC(opens sec.gov)
Jan 234
Akamine Scott0000950170-24-006666
SEC(opens sec.gov)
Dec 214
Akamine Scott0000950170-23-072375
SEC(opens sec.gov)
Dec 74
Akamine Scott0000950170-23-068887
SEC(opens sec.gov)
Feb 84
Akamine Scott0000899243-23-004362
SEC(opens sec.gov)
Aug 94
Akamine Scott0000899243-22-028185
SEC(opens sec.gov)

Companies

Address

C/O KAILERA THERAPEUTICS, INC. 180 THIRD AVENUE, 4TH FLOOR

WALTHAM, MA, 02451